H. LUNDBECK AS
914022940ActiveGlobal pharmaceutical company specializing exclusively in brain disease treatments and research.
Pharmaceutical Companylundbeck.com
Yleiskatsaus
- 9
- Työntekijät
- 63.6milj NOK
- Liikevaihto
- 1948
- Perustettu
Avainpäättäjät
Agathe Le Lay
Head of Global Value Evidence and Patient Insights
@lundbeck.com
Karin Hamberg
Chief Medical Officer
@lundbeck.com
Joerg Hornstein
CFO and Executive Vice President, Corporate Functions
@lundbeck.com
Charl van Zyl
President and CEO
@lundbeck.com
+11 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Lundbeck is a specialized global pharmaceutical company dedicated exclusively to brain diseases. For over 70 years, the organization has focused intensely on neuroscience research, development, manufacturing, and commercialization of treatments. Their core purpose is advancing brain health and trans...
Angelini Pharma Nordics AB